Ngh***yen

Biotechnology, Strategy, Start-ups, Financial Modeling

Vice President, Corporate Development at AnaptysBio

• Location: San Diego, California, United States
• Duration: 2023-09 to Present
• Description: AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. It is developing immune cell modulators, including two checkpoint agonists in clinical-stage development, for autoimmune and inflammatory disease.

Vice President, Head of Corporate Development at Medikine, Inc.

• Location: Menlo Park, California, United States
• Duration: 2021-11 to 2023-06
• Description: Medikine is a biotech with a mission to transform the discovery of oncology, autoimmune disorder and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular “PEPTIKINES”- peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Responsibilities: -Shape and execute corporate strategy initiatives to grow platform and pipeline -Drive deal sourcing, due diligence, negotiation, and execution of transactions -Lead corporate communications

Director, Head of Business Development and Alliance Management at Ascendis Pharma A/S

• Location: San Francisco Bay Area
• Duration: 2020-09 to 2021-10
• Description: Ascendis is applying its TransCon platform to build a leading biopharma company focused on making a meaningful difference in patients’ lives Responsibilities: • Chaired BD Leadership Committee and engage with CEO, CFO, CLO, SVP of Research, and VP of Strategy and Program Management to develop and execute overall BD strategy • Drove efforts to evaluate buy-side and prioritize sell-side opportunities for partnering and led all negotiation and contracting • Formalized, hired, and built alliance management function to support joint venture with Vivo Capital

Associate Director, Corporate Development at Global Blood Therapeutics

• Location: San Francisco Bay Area
• Duration: 2016-04 to 2020-09
• Description: GBT is a commercial-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Responsibilities: •Led annual long-range planning, P&L forecasting, valuation, and takeover defense advisory work with JPMorgan, Centerview, and Cravath •Sourced buy-side opportunities, led diligence, supported termsheet negotiation and contracting Past Project(s): •Drove New Opportunities Assessment effort with Chief Scientific Officer and Chief Medical Officer to identify new molecular targets in hemoglobinopathies and benign hematology for R&D

Manager, Business Development and Corporate Strategy at Aptose Biosciences, Inc.

• Location: San Francisco Bay Area
• Duration: 2014-09 to 2016-04
• Description: Aptose Biosciences is a science-driven biotechnology company advancing first-in-class therapeutics to treat hematologic malignancies, such as acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) Responsibilities: • Drove identification and due diligence of external opportunities • Supported negotiations of three agreements: one MSA and two in-licensing agreements • Synthesized scientific, clinical, and commercial competitive intelligence to support decision making • Built valuation and market revenue models for strategic planning and portfolio management